Please login to the form below

Not currently logged in


This page shows the latest Kengreal news and features for those working in and with pharma, biotech and healthcare.

FDA gives the nod to TMC's antiplatelet drug

FDA gives the nod to TMC's antiplatelet drug

FDA gives the nod to TMC's antiplatelet drug. Kengreal approved in the US three months after it got the green light in Europe. ... The Medicines Company (TMC) has finally won US approval for its injectable antiplatelet drug Kengreal for the prevention of

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    911. The Medicines Company/ Chiesi. Product acquisition. Acquisition of cardiovascular assets Cleviprex, Kengreal and rights to Argatroban.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...